US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by NeurAxis, Inc.

< Previous 1 2 Next >
News headline image
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Reports Second Quarter 2024 Financial Results
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Reports First Quarter 2024 Financial Results
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces New Medical Policy Coverage in North Dakota
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces Highmark BCBS Policy Coverage
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Reports Third Quarter 2023 Financial Results
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces CareFirst BCBS Policy Coverage
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Secures $3 Million Financing
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
From NeurAxis, Inc.
Via GlobeNewswire
News headline image
NeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders
From NeurAxis, Inc.
Via GlobeNewswire
< Previous 1 2 Next >